Charles River Laboratories International Inc
Change company Symbol lookup
Select an option...
CRL Charles River Laboratories International Inc
GBCI Glacier Bancorp Inc
HEPA Hepion Pharmaceuticals Inc
MATX Matson Inc
TECK Teck Resources Ltd
BCBNF Base Carbon Inc
PAVM PAVmed Inc
HTGC Hercules Capital Inc
NRG NRG Energy Inc
NLTX Neoleukin Therapeutics Inc
Go

Health Care : Life Sciences Tools & Services | Mid Cap Blend
Company profile

Charles River Laboratories International, Inc. is a full service, non-clinical contract research company. The Company provides research models required in research and development of new drugs, devices, and therapies. The Company's segments include Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and GMP-compliant cells businesses. The DSA segment includes services required to take a drug through the early development process, including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions (Biologics), and Avian Vaccine Services (Avian).

Closing Price
$226.32
Day's Change
5.74 (2.60%)
Bid
--
Ask
--
B/A Size
--
Day's High
226.43
Day's Low
220.23
Volume
(Below Average)
Volume:
497,125

10-day average volume:
569,648
497,125
  • Prev Close
    220.58
  • Today's Open
    222.75
  • Day's Range
    220.23-226.43
  • Avg Vol (10-day)
    569.6K
  • Last (time)
    7:00p ET 06/24/22
  • Last (size)
    1
  • 52-Wk Range
    203.37 - 460.21
    LowHigh
  • (09/24/21 - 06/14/22)
    11.28%
  • 38.9%
  • Market Cap
    11.5B
  • Shares Outstanding
    50.8M
  • 8.21
  • 27.58x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.3
  • 92.84
  • (% of float 05/31/22)
    1.96

Latest News

June 23, 2022
8:00 am ET
BusinessWire
June 13, 2022
8:00 am ET
BusinessWire
June 08, 2022
7:44 am ET
MarketWatch
7:14 am ET
MarketWatch
7:13 am ET
MarketWatch
7:13 am ET
MarketWatch
7:12 am ET
MarketWatch
June 06, 2022
8:00 am ET
BusinessWire
May 05, 2022
5:59 am ET
MarketWatch
May 04, 2022
7:00 am ET
BusinessWire
April 27, 2022
8:00 am ET
BusinessWire
April 13, 2022
4:30 pm ET
BusinessWire
April 07, 2022
8:00 am ET
BusinessWire
April 06, 2022
8:00 am ET
BusinessWire
January 10, 2022
5:02 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.